Terms: = Thyroid cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
65 results:
1. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
2. Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
Tumati A; Egan CE; Lee-Saxton YJ; Marshall TE; Lee J; Jain K; Heymann JJ; Gokozan H; Azar SA; Schwarz J; Keutgen XM; Laird AM; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
Surgery; 2024 Jan; 175(1):234-240. PubMed ID: 37907382
[TBL] [Abstract] [Full Text] [Related]
3. Extracellular pyruvate kinase M2 induces cell migration through p-Tyr42 rhoa-mediated superoxide generation and epithelial-mesenchymal transition.
Hamza A; Cho JY; Cap KC; Hossain AJ; Kim JG; Park JB
Free Radic Biol Med; 2023 Nov; 208():614-629. PubMed ID: 37722568
[TBL] [Abstract] [Full Text] [Related]
4. Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in cancer Cells.
Zwergel C; Aventaggiato M; Garbo S; Di Bello E; Fassari B; Noce B; Castiello C; Lambona C; Barreca F; Rotili D; Fioravanti R; Schmalz T; Weyand M; Niedermeier A; Tripodi M; Colotti G; Steegborn C; Battistelli C; Tafani M; Valente S; Mai A
J Med Chem; 2023 Jul; 66(14):9622-9641. PubMed ID: 37439550
[TBL] [Abstract] [Full Text] [Related]
5. Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma.
Jiang N; Jiao B; Zhang L; Li J; Li Y; Lin C
Ann Med; 2023 Dec; 55(1):2232372. PubMed ID: 37435919
[TBL] [Abstract] [Full Text] [Related]
6. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy.
Aliyev A; Aliyeva I; Giammarile F; Talibova N; Aliyeva G; Novruzov F
Endocrinol Diabetes Metab; 2022 Nov; 5(6):e373. PubMed ID: 36149057
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast cancer.
Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
[TBL] [Abstract] [Full Text] [Related]
10. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
11. Cohort profile: Scotland's record-linkage e-cohorts of people with intellectual disabilities, and autistic people (SCIDA).
Cooper SA; Henderson A; Kinnear D; Mackay D; Fleming M; Smith GS; Hughes-McCormack LA; Rydzewska E; Dunn K; Pell JP; Melville C
BMJ Open; 2022 May; 12(5):e057230. PubMed ID: 35568493
[TBL] [Abstract] [Full Text] [Related]
12. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract] [Full Text] [Related]
13. Nogo-B promotes invasion and metastasis of nasopharyngeal carcinoma via rhoa-SRF-MRTFA pathway.
Wang J; Zhong Q; Zhang H; Liu S; Li S; Xia T; Xiao Z; Chen R; Ye Y; Liang F; Han P; Huang X
Cell Death Dis; 2022 Jan; 13(1):76. PubMed ID: 35075114
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of the risk factors for central lymph-node metastasis of cN0 papillary thyroid microcarcinoma: A retrospective study.
Liu J; Fan XF; Yang M; Huang LP
Asian J Surg; 2022 Aug; 45(8):1525-1529. PubMed ID: 34642055
[TBL] [Abstract] [Full Text] [Related]
15. Role of elastography strain ratio and TIRADS score in predicting malignant thyroid nodule.
Okasha HH; Mansor M; Sheriba N; Assem M; Abdelfattah Y; Ashoush OA; Rakha M; Abdelfattah D; El-Sawy SS; Elshenoufy M; Mohsen AA; Sedrak HK; Abdellatif AA
Arch Endocrinol Metab; 2021 May; 64(6):735-742. PubMed ID: 34033283
[TBL] [Abstract] [Full Text] [Related]
16. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Lin L; Wen J; Lin B; Chen H; Bhandari A; Qi Y; Zheng D; Wang O
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):481-491. PubMed ID: 33674820
[TBL] [Abstract] [Full Text] [Related]
17. Management of thyroid cancer: results from a German and French patient survey.
Büttner M; Rimmele H; Bartès B; Singer S; Luster M
Hormones (Athens); 2021 Jun; 20(2):323-332. PubMed ID: 33184762
[TBL] [Abstract] [Full Text] [Related]
18. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
Machens A; Lorenz K; Weber F; Dralle H
Eur J Surg Oncol; 2021 Apr; 47(4):920-923. PubMed ID: 32962888
[TBL] [Abstract] [Full Text] [Related]
19. thyroid cancer histological subtypes based on tumor size: National perspective.
Al-Qurayshi Z; Foggia MJ; Pagedar N; Lee GS; Tufano R; Kandil E
Head Neck; 2020 Sep; 42(9):2257-2266. PubMed ID: 32275122
[TBL] [Abstract] [Full Text] [Related]
20. Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
Yoon JH; Han K; Lee E; Lee J; Kim EK; Moon HJ; Park VY; Nam KH; Kwak JY
PLoS One; 2020; 15(2):e0228968. PubMed ID: 32053670
[TBL] [Abstract] [Full Text] [Related]
[Next]
